The collaboration fuses EVQLV’s expertise in AI-enabled antibody design & Manhattan BioSolutions’ expertise in antibody development in oncology
EVQLV, Manhattan BioSolutions Enter Strategic Collaboration to Discover Novel Antibody Therapies
read more